EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

A STUDY ON DRUG UTILIZATION PATTERN IN PATIENTS OF TYPE II DIABETES MELLITUS ATTENDING REFERRAL DIABETIC CLINIC AT A TERTIARY CARE TEACHING HOSPITAL IN RURAL BENGAL

Tamoghna Maiti, Sourav Chakrabarty*, Sonai Mandal, Amrita Panda, Tanmoy Gangopadhyay, Satrajit Dan

ABSTRACT

Introduction: Type II DM is a pandemic metabolic disorder with great burden of complications. Intensive glycemic control often needs several anti-diabetic drugs with substantial cost. It is crucial to monitor prescriptions periodically for promoting rational pharmacotherapy and improving patient compliance. Aims & Objectives: To assess the prescription pattern of anti-diabetic drugs in patients of Type II DM along with the drugs needed for the treatment of co-morbidities. Methodology: It was a cross-sectional, institutional based, observational study done at diabetic OPD at B.S. Medical College for a duration of three months. At the exit point, information was collected in pre-structured case report form including socio-demographic profile, histories of diabetes, co-morbidities if any, relevant investigations and details of medications after obtaining written consent. Result: Among 202 patients majority were males. Three forth of patients suffered from DM for less than 5 years of duration. Two third of them had one or more co-morbidities. A total of 726 drugs were prescribed of which nearly half were anti-diabetic drugs. Metformin was the leading used anti-diabetic drug given to 77.2% of patients. Newer OHAs were used only as part of combination therapy. Only 14 patients received Insulin. Statin and anti-hypertensive were used in good percentage. Average cost of prescription per day per patient was 26.33 INR. Conclusion: Number of drugs prescribed was less than contemporary drug utilization studies. It was a very short duration study incorporating only 202 patients. In future we plan to undertake this with larger number of patients in multiple centers.

Keywords: Type II Diabetes Mellitus, Drug utilization study.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )